RSS Feed Print
Something about MS
Posted: Friday, July 5, 2013 8:03 AM
Joined: 12/21/2011
Posts: 62

A skin patch containing a mixture of myelin peptides significantly reduced clinical and imaging evidence of disease activity in patients with relapsing-remitting multiples sclerosis in a controlled trial conducted in Poland. 


Results  All patients completed the study. Compared with placebo, treatment with a myelin peptide skin patch (1 mg) showed a 66.5% reduction in the cumulative number of Gd+ lesions (P =  .02) during the 12 months of the study. The annual relapse rate in patients treated with a mixture of myelin peptides (1 mg) was significantly lower compared with the placebo group (0.43 vs 1.4; P = .007). Treatment with a myelin peptide skin patch was well tolerated and no serious adverse events were reported.